These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27613044)

  • 1. Dissecting SUMO Dynamics by Mass Spectrometry.
    Drabikowski K; Dadlez M
    Methods Mol Biol; 2016; 1449():291-8. PubMed ID: 27613044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Substrates of Protein-Group SUMOylation.
    Psakhye I; Jentsch S
    Methods Mol Biol; 2016; 1475():219-31. PubMed ID: 27631809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Label-Free Identification and Quantification of SUMO Target Proteins.
    Hendriks IA; Vertegaal AC
    Methods Mol Biol; 2016; 1475():171-93. PubMed ID: 27631806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of SUMO target proteins by quantitative proteomics.
    Andersen JS; Matic I; Vertegaal AC
    Methods Mol Biol; 2009; 497():19-31. PubMed ID: 19107408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The post-translational modification, SUMOylation, and cancer (Review).
    Han ZJ; Feng YH; Gu BH; Li YM; Chen H
    Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of SUMO-conjugated proteins and their SUMO attachment sites using proteomic mass spectrometry.
    Wohlschlegel JA
    Methods Mol Biol; 2009; 497():33-49. PubMed ID: 19107409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction.
    Cooper HJ; Tatham MH; Jaffray E; Heath JK; Lam TT; Marshall AG; Hay RT
    Anal Chem; 2005 Oct; 77(19):6310-9. PubMed ID: 16194093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
    Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
    Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the SUMOylated landscape.
    Eifler K; Vertegaal AC
    FEBS J; 2015 Oct; 282(19):3669-80. PubMed ID: 26185901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of SUMOylated Proteins in Cells and In Vivo Using the bioSUMO Strategy.
    Pirone L; Xolalpa W; Mayor U; Barrio R; Sutherland JD
    Methods Mol Biol; 2016; 1475():161-9. PubMed ID: 27631805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of SUMOylated Phytochromes in Plants.
    Orosa B; Viczián A
    Methods Mol Biol; 2019; 2026():69-83. PubMed ID: 31317403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Chemical and Enzymatic Approach to Study Site-Specific Sumoylation.
    Albuquerque CP; Yeung E; Ma S; Fu T; Corbett KD; Zhou H
    PLoS One; 2015; 10(12):e0143810. PubMed ID: 26633173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific identification and quantitation of endogenous SUMO modifications under native conditions.
    Lumpkin RJ; Gu H; Zhu Y; Leonard M; Ahmad AS; Clauser KR; Meyer JG; Bennett EJ; Komives EA
    Nat Commun; 2017 Oct; 8(1):1171. PubMed ID: 29079793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics strategies to identify SUMO targets and acceptor sites: a survey of RNA-binding proteins SUMOylation.
    Filosa G; Barabino SM; Bachi A
    Neuromolecular Med; 2013 Dec; 15(4):661-76. PubMed ID: 23979992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of cellular SUMO and SUMO-ubiquitin hybrid conjugates.
    Schnellhardt M; Uzunova K; Bade VN; Krause A; Weisshaar SR; Praefcke GJ; Dohmen RJ
    Methods Mol Biol; 2012; 832():81-92. PubMed ID: 22350877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of changes in SUMO-2/3 modification during breast cancer progression and metastasis.
    Subramonian D; Raghunayakula S; Olsen JV; Beningo KA; Paschen W; Zhang XD
    J Proteome Res; 2014 Sep; 13(9):3905-18. PubMed ID: 25072996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific proteomic strategies to identify ubiquitin and SUMO modifications: Challenges and opportunities.
    Trulsson F; Vertegaal ACO
    Semin Cell Dev Biol; 2022 Dec; 132():97-108. PubMed ID: 34802913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMOylation pathway in Trypanosoma cruzi: functional characterization and proteomic analysis of target proteins.
    Bayona JC; Nakayasu ES; Laverrière M; Aguilar C; Sobreira TJ; Choi H; Nesvizhskii AI; Almeida IC; Cazzulo JJ; Alvarez VE
    Mol Cell Proteomics; 2011 Dec; 10(12):M110.007369. PubMed ID: 21832256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The small ubiquitin-like modifier (SUMO)-conjugating system of Toxoplasma gondii.
    Braun L; Cannella D; Pinheiro AM; Kieffer S; Belrhali H; Garin J; Hakimi MA
    Int J Parasitol; 2009 Jan; 39(1):81-90. PubMed ID: 18761012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of protein SUMOylation in rheumatoid arthritis.
    Dehnavi S; Sadeghi M; Johnston TP; Barreto G; Shohan M; Sahebkar A
    J Autoimmun; 2019 Aug; 102():1-7. PubMed ID: 31078376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.